What J&J Gets Out Of JLABS Incubators
Kara Bortone, head of Johnson & Johnson Innovation's JLABS site in San Diego and interim head of the group's newest incubator site in Belgium, on the benefits of JLABS for the companies involved and the big pharma itself.
You may also be interested in...
A selection of articles you might have missed from July 2020, including exclusive interviews with industry leaders and a review of Q2 financing statistics.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
The stereotypical view of an Alzheimer’s patient as an elderly person needs to change and interventions made earlier in the disease course, while we wait for novel drug therapies, said experts at a recent virtual meeting.